- Describe recent advances in biologic drug development, regulations, and indications in immune-mediated inflammatory diseases (IMIDs), with emphasis on psoriasis, PsA and AD.
- Critically appraise and discuss relevant evidence on pathophysiology and immunology as applied to psoriasis, psoriatic arthritis and atopic dermatitis.
- Develop strategies to predict, prevent, and treat potential side effects and complications encountered with biologic agents.
- Review data regarding associated comorbid conditions associated with psoriasis, PsA, and AD including but not limited to cardiovascular disease, diabetes, obesity, and depression.
- Analyze recent investigations on safety, efficacy, and toxicity of biologic agents across IMIDs.
- Through case-based presentation and discussion panels, summarize updates in diagnosis, classification, therapies, and immune-system targets in psoriasis, PsA, and AD and describe their clinical implications.
Biologic Bootcamp faculty
The nationally known thought leadership who will present and participate in discussion panels throughout the Bootcamps includes the following psoriasis and AD experts:
Wendy Cantrell, CRNP, DNP
Doctor of Nursing Practice specializing in Dermatology
Associate Professor of Dermatology
University of Alabama
David E. Cohen, MD, MPH
Charles C. and Dorothea E. Harris Professor of Dermatology
Ronald O. Perelman Department of Dermatology
Vice Chair for Clinical Affairs
Director of Occupational Environmental and Allergic Dermatology
New York University
New York, NY
Kara Gooding, MMS, PA-C
Center for Dermatology and Plastic Surgery
Jayme Heim, MSN, APRN-BC, FNP
West Michigan Dermatology
Grandville and Holland, MI
Joseph Gorelick, MSN, FNP-C
Founder, Dermatology Education Foundation
California Skin Institute
San Jose-Los Gatos, CA
Leon Kircik, MD, FAAD
Clinical Associate Professor
University of Louisville
Physicians Skin Care
Kristine Kucera, PA-C, MPAS
Assistant Clinical Professor
University of Texas Southwestern
Medical Center PA Program
The Dermatology Education Foundation will be conducting regional CME events to provide NPs and PAs with in-depth disease specific training courses. These courses will focus on the pathophysiology, assessment, diagnosis, and treatment of psoriasis, atopic dermatitis (AD), and psoriatic arthritis (PsA). Immunology as well as existing and emerging therapies will be presented through lectures, panel discussions, and discussion sessions lead by thought leaders.